Cidara Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cidara Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1% to $63,905,000. The net income raised on -$22,931,000 and profit margin reached -36%. Total operating expenses were $86,865,000.
Profit Margin
| 2014 | 0 | -11.89M | |
|---|---|---|---|
| 2015 | 0 | -32.19M | |
| 2016 | 0 | -48.16M | |
| 2017 | 0 | -55.72M | |
| 2018 | 0 | -59.01M | |
| 2019 | 20.91M | -40.08M | -191.66% |
| 2020 | 12.06M | -72.37M | -599.76% |
| 2021 | 49.57M | -43.90M | -88.58% |
| 2022 | 64.28M | -29.79M | -46.35% |
| 2023 | 63.90M | -22.93M | -35.88% |
CDTX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 63.90M | 64.28M | 49.57M | 12.06M | 20.91M | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.52M | 143K | 189K | 68.01M | 46.40M | 0 | 667K | 0 | 461K | 0 |
Gross profit | 62.38M | 64.14M | 49.38M | -55.95M | -25.48M | 0 | -667K | 0 | -461K | 0 |
Operating exp. | ||||||||||
Research and development | 68.53M | 75.52M | 73.08M | 68.01M | 46.40M | 49.14M | 42.82M | 35.69M | 23.47M | 6.71M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 86.86M | 94.00M | 91.82M | 83.91M | 62.63M | 63.28M | 55.72M | 48.43M | 32.31M | 10.01M |
Operating income | -24.48M | -29.71M | -42.25M | -71.84M | -41.72M | -63.28M | -55.72M | -48.43M | -32.31M | -11.62M |
Other income (expenses), net | 1.99M | 191K | -212K | -262K | 632K | 3.64M | -7K | 271K | 120K | -1.87M |
Income before tax | -22.48M | -29.52M | -42.46M | -72.11M | -41.09M | -59.01M | -55.72M | -48.16M | -32.19M | -11.89M |
Income tax expense | 443K | 272K | 1.44M | 262K | -1.00M | 4.26M | -667K | -732K | -461K | 1.69M |
Net income | -22.93M | -29.79M | -43.90M | -72.37M | -40.08M | -59.01M | -55.72M | -48.16M | -32.19M | -11.89M |
Earnings per share | ||||||||||
Basic EPS | -5.25 | -8.53 | -16.75 | -34.83 | -26.78 | -45.62 | -63.69 | -66.49 | -46.76 | -290.15 |
Diluted EPS | -5.25 | -8.53 | -16.74 | -34.83 | -26.78 | -45.62 | -63.69 | -66.49 | -46.76 | -290.15 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |